$WOOFBearishMed

Petco Stock Drops After Mixed Q1 Earnings Report - Petco Health and Wellness (NASDAQ:WOOF)

Petco Health and Wellness (WOOF) reported Q1 adjusted losses of 5 cents per share, worse than the 1-cent loss expected, according to Benzinga Pro. Revenue was $1.5 billion, slightly above the $1.49 billion estimate. Petco reaffirmed fiscal 2026 sales guidance of $5.96–$6.05 billion. Shares fell 9.84% to $2.75 in extended trading, per Benzinga Pro.

9/10
6/10
Med
Bearish
after-hours/extended trading reaction to Q1 earnings
Negative—market repriced the stock lower despite reaffirmed FY2026 sales outlook.

Earnings miss on EPS (losses wider than expected) plus only modest revenue beat and FY2026 outlook reaffirmation drove a sharp negative tape reaction.

Petco reported Q1 results with losses and revenue, and reaffirmed FY2026 sales outlook as shares fell ~9.8% in extended trading.

Bearish near-term bias; watch for follow-through selling or stabilization around the post-earnings gap.

Background

Petco’s Q1 print included an EPS loss miss and a small revenue beat, followed by a reaffirmation of FY2026 sales guidance.

Why it matters

The market reaction suggests investors prioritized profitability/margin signals over revenue momentum, despite maintaining the fiscal sales range.

Market relevance

Material single-name earnings/guidance reaction with a large immediate price move.

Market effects

Read-through for specialty retail/pet services demand expectations; mixed results can pressure sentiment toward discretionary retail names.

Primarily US-listed small-cap retail sentiment; limited direct regional spillover indicated.

Low—no international or macro linkage beyond US consumer retail demand framing.

Alternative perspectives

The company beat revenue and reaffirmed FY2026 sales guidance; the selloff may be overreacting to EPS optics rather than top-line trajectory.

Investors may be focusing on margin/expense trajectory implied by the EPS miss; without segment or margin detail, the magnitude of longer-term deterioration is unclear.

Key entities

  • Petco Health and Wellness

    Reported Q1 losses and revenue; reaffirmed FY2026 sales outlook; stock dropped ~9.8% in extended trading.

Related articles

$AVGOMedAI 9/10

Futures Slide After Broadcom Forecast Miss Chills Tech Euphoria

US equity futures fell as tech stocks slid after Broadcom’s AI-chip outlook missed expectations. As of 8:00am ET, S&P futures -0.4% and Nasdaq futures -1.2%. Broadcom shares fell about 13–14% premarket; CrowdStrike dropped ~10% after its revenue forecast disappointed. Investors also watched macro data (job cuts, claims) and upcoming earnings.

$WOOFMedAI 9/10

Petco Health and Wellness Co Inc (WOOF) Q1 2026 Earnings Call Highlights: Navigating Modest...

Petco’s CEO Joel Anderson said Q1 improvements occurred across consumables, supplies/companion animals, and services, though the company has not yet gained market share and the decline has moderated. CFO Sabrina Simmons said Petco beat Q1 consensus but reaffirmed full-year guidance, absorbing expected second-half fuel costs; it is not relying on tariff refunds.

$WOOFMedAI 9/10

Petco (WOOF) To Report Earnings Tomorrow: Here Is What To Expect

Petco (NASDAQ: WOOF) is set to report earnings Wednesday afternoon. The company reported $1.52 billion in revenue last quarter, down 2.4% year over year, and met analysts’ revenue expectations while beating EBITDA estimates and raising EBITDA guidance for next quarter. For the upcoming quarter, analysts expect flat revenue growth year over year. Petco shares are up 7.9% over the past month, with an average analyst price target of $3.52 versus about $3.

$WOOFLow

JPMorgan Chase & Co. Buys 613,591 Shares of Petco Health and Wellness Company, Inc. $WOOF

JPMorgan Chase & Co. significantly increased its stake in Petco Health and Wellness Company, Inc. (WOOF) by 280.4% in the third quarter, acquiring 613,591 additional shares to hold a total of 832,412 shares. Other institutional investors like Dimensional Fund Advisors and Vanguard Group also boosted their positions. Despite these institutional buys, Petco recently missed earnings estimates, reporting ($0.01) EPS against an estimated $0.02, with revenue down 2.4% year-over-year, leading analysts to maintain a "Hold" rating with an average price target of $4.06.